Press Releases

‫شركة فينجروب تؤسس منظومة المشاريع الاجتماعية في فيتنام

تعمل مجموعة فينجروب، وهي تكتل تجاري رائد في فيتنام، على تطوير دور مؤسسات الأعمال في المجتمع، وتعمل المجموعة بنشاط على إنشاء منظومة تعزز التأثير الاجتماعي الإيجابي من خلال إنشاء مشاريع في مجالات متنوعة والالتزام العميق بالمسؤولية الاجتماعية.   هانوي، فيتنام – Media OutReach Newswire– 23 سبتمبر 2024 – في أعقاب التأثير المدمر لإعصار ياجي، شركة […]

ABR IMPORTANT DEADLINE: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Arbor Realty Trust, Inc. Investors to Secure Counsel Before Important September 30 Deadline in Securities Class Action – ABR

NEW YORK, Sept. 22, 2024 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Arbor Realty Trust, Inc. (NYSE: ABR) between May 7, 2021 and July 11, 2024, both dates inclusive (the “Class Period”), of the important September 30, 2024 lead plaintiff deadline. SO WHAT: If you purchased Arbor […]

In Vietnam, Vingroup Plants the Seeds of a Social Enterprise Ecosystem

Vingroup, a leading Vietnamese conglomerate, is redefining the role of business in society. Through a diverse portfolio and a deep commitment to social responsibility, they are actively cultivating an ecosystem that fosters positive social impact. HANOI, VIETNAM – Media OutReach Newswire – 20 September 2024 – In the wake of Typhoon Yagi’s devastating impact, Vingroup, […]

In Vietnam, Vingroup Plants the Seeds of a Social Enterprise Ecosystem

Vingroup, a leading Vietnamese conglomerate, is redefining the role of business in society. Through a diverse portfolio and a deep commitment to social responsibility, they are actively cultivating an ecosystem that fosters positive social impact. HANOI, VIETNAM – Media OutReach Newswire – 20 September 2024 – In the wake of Typhoon Yagi’s devastating impact, Vingroup, […]

Zenas BioPharma Announces Closing of Full Exercise of Underwriters’ Option to Purchase Additional Shares in Initial Public Offering

WALTHAM, Mass., Sept. 19, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced that the underwriters of its previously announced upsized initial public offering of 13,235,294 shares of its common stock, which closed […]